Frontotemporal Dementia (FTD) Frontotemporal dementia: clinical In - - PowerPoint PPT Presentation

frontotemporal dementia ftd
SMART_READER_LITE
LIVE PREVIEW

Frontotemporal Dementia (FTD) Frontotemporal dementia: clinical In - - PowerPoint PPT Presentation

Frontotemporal Dementia (FTD) Frontotemporal dementia: clinical In 1892, Arnold Pick describes a focal syndromes and pathobiology neurodegenerative condition involving the frontal and anterior temporal lobes William W. Seeley, MD


slide-1
SLIDE 1

1

Frontotemporal dementia: clinical syndromes and pathobiology

William W. Seeley, MD Associate Professor of Neurology and Pathology UCSF Recent Advances in Neurology February 13, 2014

Bruce Miller, UCSF

Frontotemporal Dementia (FTD)

  • In 1892, Arnold Pick

describes a focal neurodegenerative condition involving the frontal and anterior temporal lobes

  • Alois Alzheimer, Pick’s

student, observes that some patients harbor argyophilic “Pick bodies” unlike the neurofibrillary tangles of AD

  • FTD is a common and under-diagnosed form of early age-
  • f-onset dementia strongly linked to ALS
  • FTD refers to a canon of unique clinical syndromes that (1)

reflect focal network-based neurodegeneration and (2) generate a pathological DDX (length varies by syndrome)

  • FTLD refers to a spectrum of FTD-associated pathological

entities: FTLD-tau, -TDP-43, and -FUS; these misfolded proteins may act as prion-like “strains” that seed network- based disease spread

  • Most FTD is sporadic, but the genetics of familial FTD are

helping to shed light on disease pathogenesis

Take home points

Common cause early age-of-onset dementia

  • 1:1 with AD 45-64 years (Ratnavalli et al., Neurology 2002)
  • More common than AD when symptoms begin

before age 60 years (Knopman et al., Neurology 2004)

  • Broader FTD spectrum, including CBD/PSP and

ALS, even more common

Less common in older patients?

  • 25% had symptom onset after 65 in one FTLD

series (Barborie 2011)

  • May present with less focal cortical atrophy and a

higher rate of hippocampal sclerosis (Barborie 2012)

FTD Prevalence

slide-2
SLIDE 2

2

Frontotemporal dementia Behavioral variant (bvFTD) PPA variants Semantic variant (svPPA) Nonfluent/agrammatic variant (nfvPPA) R L R L R L FTD-MND svPPA nfvPPA FTD-MND Frontotemporal lobar degeneration (FTLD) FTLD-tau FTLD-TDP* FTLD-FUS aFTLD-U NIFID FTLD-3

CHMP2b

???

FUS

BIBD bvFTD Type A

(PGRN) (C9orf72)

Type D

VCP

Type B

(C9orf72) (TARDP?)

*Mackenzie harmonized scheme, 2011

Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

MAPT

Other CTE, AGD, MST Type C Frontotemporal lobar degeneration (FTLD) FTLD-tau FTLD-TDP* FTLD-FUS aFTLD-U NIFID FTLD-3

CHMP2b

???

FUS

BIBD Type A

(PGRN) (C9orf72)

Type D

VCP

Type B

(C9orf72) (TARDP?)

svPPA nfvPPA FTD-MND bvFTD

*Mackenzie harmonized scheme, 2011

Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

MAPT

Other CTE, AGD, MST Type C Frontotemporal lobar degeneration (FTLD) FTLD-tau FTLD-TDP* FTLD-FUS aFTLD-U NIFID FTLD-3

CHMP2b

???

FUS

BIBD Type D

VCP

Type B

(C9orf72) (TARDP?)

Type A

(PGRN) (C9orf72)

svPPA nfvPPA FTD-MND bvFTD

*Mackenzie harmonized scheme, 2011

Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

MAPT

Other CTE, AGD, MST Type C

slide-3
SLIDE 3

3

Frontotemporal lobar degeneration (FTLD) FTLD-tau FTLD-TDP* FTLD-FUS FTLD-3

CHMP2b

Type D

VCP

Type B

(C9orf72) (TARDP?)

aFTLD-U NIFID ???

FUS

BIBD svPPA nfvPPA FTD-MND bvFTD

*Mackenzie harmonized scheme, 2011

Type A

(PGRN) (C9orf72)

Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

MAPT

Other CTE, AGD, MST Type C Frontotemporal lobar degeneration (FTLD) FTLD-tau FTLD-TDP* FTLD-FUS FTLD-3

CHMP2b

Type C Type D

VCP

Type B

(C9orf72) (TARDP?)

aFTLD-U NIFID ???

FUS

BIBD

*Mackenzie harmonized scheme, 2011

Type A

(PGRN) (C9orf72)

Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

MAPT

Other CTE, AGD, MST svPPA nfvPPA PSPS CBS FTD-MND bvFTD Frontotemporal lobar degeneration (FTLD) FTLD-tau FTLD-TDP* Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

MAPT

Other CTE, AGD, MST FTLD-FUS FTLD-3

CHMP2b

Type C Type D

VCP

Type B

(C9orf72) (TARDP?)

aFTLD-U NIFID ???

FUS

BIBD Type A

(PGRN) (C9orf72)

Type U

(C9orf72)

svPPA nfvPPA PSPS CBS FTD-MND bvFTD

*Mackenzie harmonized scheme, 2011

Frontotemporal lobar degeneration (FTLD) FTLD-tau FTLD-TDP* Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

MAPT

Other CTE, AGD, MST FTLD-FUS FTLD-3

CHMP2b

Type C Type D

VCP

Type B

(C9orf72) (TARDP?)

aFTLD-U NIFID ???

FUS

BIBD Type A

(PGRN) (C9orf72)

Type U

(C9orf72)

svPPA nfvPPA PSPS CBS FTD-MND bvFTD

*Mackenzie harmonized scheme, 2011 Alzheimer’s Disease

slide-4
SLIDE 4

4

bvFTD

AD (PS1), 1

ALS-TDP, 5

TDP-B, 14

TDP-U*, 5

bvFTD-MND

GGT, 1 Pick's, 1

TDP-C, 14

TDP-U, 1

svPPA nfvPPA

PSP, 3

TAU-NOS, 1

CBD, 4

Pick's, 1

TDP-A*, 3

CBS

AD, 5

TAU-NOS, 1

CBD, 4

Pick's, 1 TDP-A*, 2

PSPS

AD/PSP, 2

PSP, 15

TAU-CBD, 1 Pick's, 1 CJD, 1

UCSF Neurodegenerative Disease Brain Bank

Patient D.C.

58 y.o. business executive with 2 high school children Brought in by wife for increasingly uncharacteristic behaviors:

  • No longer interested in son’s school and sports activities
  • Rises to board aircraft during each boarding call
  • Repeatedly takes out wallet to illustrate the shape of Kansas
  • New penchant for sweets; overeating in general, gains weight

Language, memory, navigation, skilled movements all normal.

Patient D.C.

Right

R L

Anterior Cingulate Cortex (ACC) and Rostromedial PFC Fronto- insula (FI)

slide-5
SLIDE 5

5

Frontotemporal lobar degeneration (FTLD) svPPA FTD-MND FTLD-tau FTLD-TDP* Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

(MAPT)

Tau NOS MST/AGD FTLD-FUS FTLD-3

(CHMP2b)

nfvPPA Type C Type D

(VCP)

Type B

(C9ORF72) (TARDP?)

aFTLD-U NIFID ???

(FUS)

BIBD PSPS CBS

*Mackenzie harmonized scheme, 2011

Type A

(PGRN) (C9ORF72)

bvFTD

R

Frontal Insula (FI)

bvFTD due to Pick’s Disease (FTLD-tau)

H & E GFAP

slide-6
SLIDE 6

6

3R tau H & E

bvFTD due to Pick’s Disease (FTLD-tau)

Seeley et al J Neurosci 2007

In healthy subjects, baseline low frequency fMRI BOLD signal fluctuations in Right FI are correlated with…

Frontal pole FI FI ACC SLEA VSP Hypothalamus Lat OFC

Left Right

Intrinsic connectivity measured with fcMRI

DLPFC

Right FI seed ROI

3T fcMRI 19 healthy controls Time (sec) Single subject

“Salience Network” (Intrinsic connectivity network)

R

Fronto- insula (FI)

Seeley et al J Neurosci 2007

In healthy subjects, baseline low frequency fMRI BOLD signal fluctuations in Right FI are correlated with… Right FI seed ROI

3T fcMRI 19 healthy controls

“Salience Network” (Intrinsic connectivity network)

DeAruojo 2003

THIRST

Rainville 1997

PAIN

Singer 2004

SPOUSE’S PAIN

Bartels and Zeki, 2004

LOVERS HR DETECTION

Critchley 2004

Intrinsic connectivity measured with fcMRI

Across healthy subjects, gray matter volume in Right FI is correlated with… Right FI seed ROI

1.5T T1 MRI 65 healthy controls

S1 S2 S3 S4 S5 S6 S7

“Salience Network” (Intrinsic connectivity network)

Structural covariance measured with “scMRI”

slide-7
SLIDE 7

7

bvFTD

Functional connectivity Right FI seed fMRI, healthy controls N = 19 Structural covariance Right FI seed VBM, healthy controls N = 65 bvFTD atrophy pattern VBM, patients < controls N = 24 Overlap

Seeley et al Neuron 2009

bvFTD

bvFTD atrophy pattern VBM, patients vs. controls N = 24 bvFTD pattern N seed-based maps

Which regions serve as a gateway to the network? epicenters

bvFTD

bvFTD atrophy pattern VBM, patients vs. controls N = 24 bvFTD pattern Healthy correlation matrix

E

Healthy network graph

Does a node’s connectivity predict its vulnerability?

bvFTD-vulnerable “salience network”

Zhou et al 2012

L

slide-8
SLIDE 8

8

bvFTD epicenters

R

bvFTD epicenters

R

bvFTD target network epicenters

Patient C.N.

  • 47 y.o. RH former foundation group leader with no

complaints other than “mild memory problems” Brought in by wife for 10-15 years slowly progressive behavior change:

  • Brought home books on death and dying to read to 3 y.o.

daughter at bedtime

  • Took up computer Solitaire, counted white cars
  • Failed to initiate job search when laid off
  • Urination ritual: To and from BR x 4 QHS
  • Mild verbal memory impairment; no executive, language,
  • r motor deficits
slide-9
SLIDE 9

9

Patient C.N.

Frontotemporal lobar degeneration (FTLD) svPPA FTD-MND FTLD-tau FTLD-TDP* Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

(MAPT)

Tau NOS MST/AGD FTLD-FUS FTLD-3

(CHMP2b)

nfvPPA Type C Type D

(VCP)

Type B

(C9ORF72) (TARDP?)

aFTLD-U NIFID ???

(FUS)

BIBD PSPS CBS

*Mackenzie harmonized scheme, 2011

Type A

(PGRN) (C9ORF72)

bvFTD

mOFC uncus CA1/subic

bvFTD due to aFTLD-U (FTLD-FUS)

Working model: anatomical convergence

Different diseases, same onset, same spread bvFTD

Tau, TDP-43, or FUS Pick’s (Tau) TDP-43 Type B aFTLD-U (FUS)

E

slide-10
SLIDE 10

10

Early psychiatric mis-diagnoses

  • Bipolar illness
  • Schizophrenia
  • Major Depression
  • Addiction Disorder (multiple types)
  • Personality Disorders

– Borderline – Passive-aggressive – Antisocial – Schizoid – Schizotypal

Bora et al, Biol Psych 2010

Relationship between bvFTD anatomy and psychiatric disease

Imaging (VBM, PET) meta-analyses

Schroeter et al, Neurobiol Aging 2006 Fornito et al, Schiz Res 2009

1 3

bvFTD

schizophrenia bipolar disorder

2

Patient A.T.

61 y.o. high school counselor with 5 years of word-finding and word recognition difficulties. Asks husband to explain words in the newspaper. Later:

  • Approaches strangers for idle conversation
  • Obsessed with vitamins, takes 15/day
  • Prefers sweets and chips, gains 10#

Patient A.T.

Exam:

  • Surface dyslexia, questions

meaning of individual words

  • Fluency and repetition spared

until late

  • No motor or visuospatial/
  • navigation deficits
slide-11
SLIDE 11

11 Object knowledge regresses to category prototypes

“horse” “dog”

Frontotemporal lobar degeneration (FTLD) svPPA FTD-MND FTLD-tau FTLD-TDP* Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

(MAPT)

Tau NOS MST/AGD FTLD-FUS FTLD-3

(CHMP2b)

nfvPPA Type C Type D

(VCP)

Type B

(C9ORF72) (TARDP?)

aFTLD-U NIFID ???

(FUS)

BIBD PSPS CBS

*Mackenzie harmonized scheme, 2011

Type A

(PGRN) (C9ORF72)

bvFTD

H & E TDP-43 L amygdala L amygdala L anterior ITG

Semantic variant PPA due to FTLD-TDP, Type C Semantic variant PPA due to FTLD-TDP, Type C

  • Long, swollen, dystrophic neurites in superficial > deep layers: Type C
  • Relatively few neuronal cytoplasmic inclusions, except in dentate gyrus and nucleus

accumbens

slide-12
SLIDE 12

12

L Insula R Insula Orbital Frontal Anterior Cingulate Orbital Frontal R Amy/Tpole L Amy/Tpole

Left Right

Semantic Variant PPA

Rosen et al 2002 Seeley et al Neuron 2009; Zhou et al, Neuron 2012; Guo et al, Brain 2013

Semantic-appraisal network: decoding and evaluating context

Network-based neurodegeneration

Time (sec) Single subject

S1 S2 S3 S4 S5 S6 S7 Seeley et al, Neuron 2009 svPPA nfvPPA Zhou et al, Neuron 2012

svPPA nfvPPA

Does each vulnerable network harbor a key epicenter or epicenters?

slide-13
SLIDE 13

13

Relationship between intrinsic connectivity in health and vulnerability to disease

bvFTD pattern svPPA pattern CBS pattern nfvPPA pattern AD pattern bvFTD pattern svPPA pattern CBS pattern nfvPPA pattern AD pattern

Healthy connectivity graph

Connectomic prediction of regional vulnerability

Intrinsic functional connectivity

bvFTD pattern SD pattern CBS pattern PNFA pattern AD pattern

Atrophy severity in disease

bvFTD pattern SD pattern CBS pattern PNFA pattern AD pattern

Healthy connectivity graph

Atrophy severity in disease

E

Intrinsic functional connectivity

Connectomic prediction of regional vulnerability

slide-14
SLIDE 14

14

bvFTD pattern SD pattern CBS pattern PNFA pattern AD pattern

Healthy connectivity graph

Atrophy severity in disease

E

Intrinsic functional connectivity

Connectomic prediction of regional vulnerability

bvFTD pattern SD pattern CBS pattern PNFA pattern AD pattern

Healthy connectivity graph

Atrophy severity in disease

E

Intrinsic functional connectivity

Connectomic prediction of regional vulnerability

bvFTD pattern SD pattern CBS pattern PNFA pattern AD pattern

Healthy connectivity graph

Atrophy severity in disease

E

Intrinsic functional connectivity

Connectomic prediction of regional vulnerability

bvFTD pattern SD pattern CBS pattern PNFA pattern AD pattern

Healthy connectivity graph

Atrophy severity in disease

E

Connectomic prediction of regional vulnerability

Intrinsic functional connectivity

slide-15
SLIDE 15

15

FTLD-tau FTLD-TDP* FTLD-FUS FTLD-3

CHMP2b

nfvPPA Frontotemporal lobar degeneration (FTLD) Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

(MAPT)

Other CTE, AGD, MST Type C Type D

(VCP)

Type B

(C9orf72) (TARDP?)

aFTLD-U NIFID ???

(FUS)

BIBD Type A

(PGRN) (C9orf72)

Type U

(C9orf72)

*Mackenzie harmonized scheme, 2011

svPPA PSPS CBS FTD-MND bvFTD

nfvPPA due to… nfvPPA due to…

CP-13 IHC for hyperphosphorylated tau

PSP

slide-16
SLIDE 16

16

FTLD-tau Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

(MAPT)

Other CTE, AGD, MST

*Mackenzie harmonized scheme, 2011

PSPS Frontotemporal lobar degeneration (FTLD) FTLD-TDP* FTLD-FUS FTLD-3

CHMP2b

nfvPPA Type C Type D

(VCP)

Type B

(C9orf72) (TARDP?)

aFTLD-U NIFID ???

(FUS)

BIBD Type A

(PGRN) (C9orf72)

Type U

(C9orf72)

svPPA CBS FTD-MND bvFTD

A midbrain-anchored network vulnerable in progressive supranuclear palsy

Time (sec) Single subject

ROI seed =

rostral midbrain tegmentum

Boxer et al, 2006

Reduced network connectivity in PSP-S

Gardner et al, Annals of Neurology 2013 p < 0.05 joint height/extent p < 0.01 joint height/extent

PSP<HC3

PSP CBD Clinically atypical CDR sum of boxes

X

A152T

rMT ICN score (mean beta value)

Frontotemporal lobar degeneration (FTLD) FTLD-tau FTLD-TDP* Pick’s 3R tau CBD 4R tau PSP 4R tau FTDP-17

MAPT

Other CTE, AGD, MST FTLD-FUS FTLD-3

CHMP2b

Type C Type D

VCP

Type B

(C9orf72) (TARDP?)

aFTLD-U NIFID ???

FUS

BIBD Type A

(PGRN) (C9orf72)

Type U

(C9orf72)

svPPA nfvPPA PSPS CBS FTD-MND bvFTD

*Mackenzie harmonized scheme, 2011

slide-17
SLIDE 17

17

C9ORF72

  • Gene/mutation: GGGGCC repeat expansion (normal 2–23,

abnormal 400–1600)

  • Epi: 12% all FTD, 24% familial ALS or familial FTLD (> 50%

familial FTD at UCSF)

  • Syndrome: bvFTD, FTD/MND, ALS, less often

PPA/PSP/CBS/HD

  • Path: TDP-43 type B (less often A or U), dipeptide repeat

protein inclusions

  • MRI: symmetric atrophy dorsolateral, medial and orbital

frontal, insular, anterior temporal, parietal, occipital, thalamus, +/- cerebellum

RNA-mediated Neurodegeneration

  • RNA noncoding regions; toxic gain-of-function

– C9ORF72 – Myotonic dystrophy – Fragile X-tremor ataxia syndrome

  • Transcriptional alterations generate sense and

antisense repeat transcripts, sequester mRNA- associated protein complexes; lead to aberrant mRNA splicing and processing

Todd, Paulson, Ann Neurol 2010

Nuclear RNA Foci in Brain and Cord

Dejesus-Hernandez et al, Neuron, 2011

Anti-C9RANT immunoreactivity is specific to C9FTD/ALS

Ash et al, Neuron 2013

Some mRNA translated (non-ATG) into dipeptide repeat proteins that aggregate in cytoplasm

slide-18
SLIDE 18

18

MAPT

  • Gene/Mutation: Microtubule associated protein tau, Chr 17.

In most cases, intron mutation, splice in exon 10, or mutations in exons 9–13

  • Epi: 3–14% all FTD, 17% familial FTD at UCSF
  • Syndrome: usually bvFTD, PSP preceded by depression,

addiction, mood instability

  • Path: Unclassifiable tauopathy
  • MRI: Symmetric, anteromedial temporal lobes, anterior

insula, OFC, fornix

Rohrer 2009 & 2011

GRN

  • Gene: GRN, encoding progranulin, Chr 17
  • Epi: 1–16% all FTLD, 8% familial FTLD at UCSF
  • Syndrome: Usually bvFTD, PNFA, or less likely
  • CBS. 10% > 70 without symptoms
  • Path: TDP-43 type A (NCIs and threads, NIIs)
  • Sx/Signs: mean onset 62, episodic memory

impairment, parkinsonism

  • MRI: more dorsal asymmetric atrophy affecting

inferior frontal, temporal, inferior parietal lobes, medial thalamus, and basal ganglia

Rohrer et al Curr Op Neurol 2011

Progranulin

  • Secreted glycoprotein with growth factor-like and

immunomodulatory activities

  • TNF receptor antagonist-like activity; also binds

Sortilin receptormaster regulator of inflammation?

  • Contains 7 full and one ½-length granulin domains,

which are released following proteolytic cleavage

  • > 60 pathogenic GRN mutations reported in FTD,

all expected to result in haploinsufficiency

C9orf72 MAPT GRN Age at Dx 56 52 62 Clinical bvFTD, ALS, or FTD-ALS bvFTD, PSP, CBD bvFTD, nfvPPA, CBS, AD MRI Mild, symmetric, dorsal, thal & cereb Symmetric ATL-OFC Asymmetric fronto- parietal, temporal in some Unique clinical Postural tremor, ALS, smoldering psychiatric prodrome Suicide, addiction Posterior deficits:

  • verlap with AD

Unique biology RNA-mediated, RAN translation 3R/4R tauopathy, tau dysfunction Haploinsufficiency

slide-19
SLIDE 19

19

Lingering questions and challenges

  • Anatomical convergence = pathological

heterogeneity for a given syndrome. Unifying principle?

  • Anatomical divergence = syndromic

heterogeneity for a given pathology. Protein strains?

  • Variable age-of-onset and disease
  • kinetics. Background genetics? Strain

diversity?

Acknowledgments

Seeley Lab Raquel Gardner Stephanie Gaus Christine Guo Norbert Lee Alissa Nana Li Manu Sidhu Andrew Trujillo Formerly: Danielle Carlin Maria Cobos (MGH) Rich Crawford Stathis Gennatas (PENN) *Eun-Joo Kim (Pusan) *Helen Zhou (Duke-NUS, Singapore) Cal Tech John Allman MSSM Patrick Hof Barrow Neurological A.D. (Bud) Craig UCI Brain Bank Elizabeth Head Stanford University Michael Greicius Vinod Menon UCSF ADRC Pathology Core Ben Arevalo Kelly Creighton Steve DeArmond Lea Grinberg Eric Huang Jian Yang Jakc Whittembury UCSF Memory & Aging Center Adam Boxer Marilu Gorno-Tempini Suzee Lee *Bruce Miller Howard Rosen Virginia Sturm Michael Weiner Funding Sources: National Institute on Aging Alzheimer’s Drug Discovery Foundation Association for Frontotemporal Dementia Larry L. Hillblom Foundation James S. McDonnell Foundation John D. French Alzheimer’s Foundation UCSF Consortium for FTD Research Tau Consortium Hellman Family Foundation John D. and Catherine T. MacArthur Foundation

Progranulin: A New FTD Gene

  • Hutton & Van Broeckhoven independently found

PRG mutations in families linked to 17q21 (Cruts 2006; Baker 2006)

  • 5–10% of all FTLD cases and 23% of familial cases

seen at the Mayo Clinic have mutations (Gass 2006)

  • 24% of these cases have primary language

dysfunction (others with FTD, CBS, AD picture)

  • Family members with the same mutation can have

strikingly different phenotypes (FTD vs. PNFA) (Snowden 2006)

Tau Mutations

  • 44 mutations, 132 families
  • Exon mutation or deletion exon 9–13 (maybe

7) causes tau loss of function

  • Intron mutations increase 4R tau
  • Glial/neuronal tau inclusions
slide-20
SLIDE 20

20

Acknowledgments

Seeley Lab Jesse Brown Anke Dykstra Stephanie Gaus Alice Hua Ji-Hye Hwang Norbert Lee Alissa Nana Li Youngsoon Park Andrew Trujillo Andrew Tucker Sarat Vatsavayai Jian Yang

Formerly: Manu Sidhu Danielle Carlin Inma Cobos (MGH) Rich Crawford Stathis Gennatas (PENN) Christine Guo (Australia) Eun-Joo Kim (Korea) *Helen Zhou (Duke-NUS, Singapore)

Cal Tech John Allman MSSM Patrick Hof Barrow Neurological A.D. (Bud) Craig UCI Brain Bank Elizabeth Head Stanford University Michael Greicius Vinod Menon UCSF Brain Bank Steve DeArmond Ian Fischer-Laycock Lea Grinberg Kelly Hitchner Eric Huang Jakc Whittembury UCSF Memory & Aging Center Adam Boxer Raquel Gardner Marilu Gorno-Tempini Suzee Lee Bruce Miller Howard Rosen Virginia Sturm Michael Weiner Funding Sources: National Institute on Aging Alzheimer’s Drug Discovery Foundation Association for Frontotemporal Dementia Larry L. Hillblom Foundation James S. McDonnell Foundation John D. French Alzheimer’s Foundation Consortium for FTD Research Tau Consortium Hellman Family Foundation John D. and Catherine T. MacArthur Foundation

Progranulin

  • Double function: PGRN: Neuron growth anti-inflam

(neutrophil, IL-10) Granulin: inflam

  • Two receptors: sortilin (neuronal), TNF α (neuronal,

microglial, neutrophils)

  • Tightly regulated

– SLPI (block PGRN breakdown), elastase

  • Master regulator of inflammation?

Patient D.C.

58 y.o. business executive with 2 high school children Brought in by wife for increasingly uncharacteristic behaviors:

  • Disinterest in kids’ school and sports activities
  • Speaking out of turn, commenting on strangers’ weight or hairstyle
  • Circles the kitchen island 3 times (counterclockwise) upon entering room
  • New penchant for sweets; overeating in general

Language, memory, navigation, skilled movements all normal. Denies low mood, sleep disturbance, life stressors.

Sporadic CBS due to FTLD-TDP, Type 3

  • Copious short, angulated neurites in superficial > deep layers
  • Numerous round or crescentic neuronal cytoplasmic inclusions
  • Occasional “cat’s eye” neuronal nuclear inclusions
slide-21
SLIDE 21

21

Premotor cortex, TDP-43 antibody bvFTD-MND, Stage 1, Right FI, stained for TDP-43 20 µM

Stephanie Gaus 20 µM

Rosen et al, Neurology MR voxel-based morphometry

FTD and SD vs. controls

Grossman 2005 Boccardi 2005 Varrone 2003 Jeong 2005 Foster 2003 Turner 2005

5HT-1a (ALS) PET PET FDG SPET VBM ACC & FI involvement in FTD VBM- low tau

slide-22
SLIDE 22

22

Superior Parietal Lobule Superior Frontal Sulcus

Tau immunohistochemistry shows abundant cortical and subcortical white matter tauopathy

500 µM

I II III IV V VI WM

CP-13 antibody to hyperphosphorylated tau

Astrocytic plaques, neuropil threads, ballooned tau- immunoreactive Layer 5 neurons, & coiled bodies

50 µM 50 µM

50 µM Precentral gyrus Also seen: tufted and thorny astrocytes in numerous cortical and subcortical regions (not shown)

VEN Fork

Kim et al, Cerebral Cortex 2011

Anatomical severity Clinical severity TDP-43 aggregation

Frontoinsula

  • S. Gaus, unpublished

bvFTD bvFTD-MND svPPA nfvPPA CBS PSPS

UCSF Neurodegenerative Disease Brain Bank Patients with known mutations (n = 25)

slide-23
SLIDE 23

23

FTD Genetics

  • Genetic (40%) sporadic (60%)

– Predominantly FTD, CBD or PSP (Chromosome 17)

  • Tau – exon/intron mutations tau aggregates
  • Progranulin – nonsense mutation nuclear TDP-43

– ALS and FTD

  • Chr 1 – TDP-43 mutations (uncommon)
  • Chr 9 – C9ORF72 (common)
  • Chr 9 – Valosin (TDP43) FTD with Paget’s IBM/ALS
  • Chr 16 – FUS (still only ALS)
  • X-linked – ubiquilin-2 (uncommon)

– Rare!

  • FTD – Chromosome 3 CHMP2b
  • ?FTD with bone tumors – EXT2 – Chromosome 9

Frontotemporal dementia Behavioral variant “Language” variants Semantic Dementia Progressive Nonfluent Aphasia FTD-MND Frontotemporal dementia Behavioral variant “Language” variants Semantic Dementia Progressive Nonfluent Aphasia FTD-MND

RTLV LTLV

Visit #1 Visit #2 Visit #3

R

Henry et al 2014

slide-24
SLIDE 24

24

Corticobasal Syndrome Progressive Supranuclear Palsy

Boxer et al 2006

Dementia-Movement Disorder Tauopathies

Imaging-pathology correlation: pilot study

  • 56-year-old right-handed woman referred for progressive reading

difficulties and falls

  • First symptoms at age 50: “eyes tired” when reading, trouble navigating

stairs, fell down an escalator

  • Following 6 years: almost daily falls, uncontrollable laughter/crying,

difficulties with swallowing

Patient DM

slide-25
SLIDE 25

25

56 y.o. woman with PSP 36 months prior to death

Single patient imaging-pathology correlation analysis

56 y.o. woman with PSP 36 months prior to death

Single patient imaging-pathology correlation analysis

Single patient connectivity to rostral midbrain < 24 age-matched healthy women

Dissected tissue blocks

slide-26
SLIDE 26

26

PreCG PostCG STN Dentate Nucleus Cerebellum

phospho-tau IHC

Cortex Limbic BG Cereb/brainstem SC Cortex Limbic BG Cereb/brainstem SC

rMT intrinsic connectivity: Which pathological events disrupt connectivity?

Tau burden Astrogliosis

Regions of interest to match dissected tissue blocks

C1 E1 C4 C3 C2 E2 C5 C6 C9 C10 C8 C7 C11 E3 C17 C16 C15 C13 C14 C12 C19 C18

Regions of interest to match dissected tissue blocks

slide-27
SLIDE 27

27

ρ = 0.6 ,p = 0.001

Ln ICN reduction, Pt < HC Composite tau burden

Tau burden predicts rMT connectivity disruption

Co Ce

Me

Lat BM BL

BV

2 cm

Cortical nucleus Central nucleus

Co Ce

Me

Lat BM BL

BV

bvFTD involves distributed salience network connectivity disruptions

Zhou et al Brain 2012

bvFTD < HC

bvFTD < HC